Vitamin D Market Size, Share & Trends Analysis Report By Application, By End User, By Region, And Segment Forecasts, 2019 To 2025

The global vitamin D market is expected to witness significant growth over the forecast period. Vitamin D is a fat-soluble vitamin detected in a few foods such as meat and eggs and absorbed by the body as a dietary supplement. Exposure to sun also meets the demand for adequate vitamin D provision in the body, though certain body-synthesis or hydroxylation is a prerequisite for vitamin D activation.

Preventing the onset of hypocalcemia, osteoporosis, osteomalacia, and rickets coupled with regulating blood circulation in the body and including proper thyroid function are favorable factors driving the growth in the vitamin D market.

Increasing occurrences of diseases caused by vitamin D deficiencies and doctor recommendations in aiding vitamin D ingestion have proven to be factors abetting the market.

The restraints oppressing the market growth include regulatory standards practiced by specific regions in preventing undesirable vitamin D toxicity.

Developments undertaken by emerging economies such as China, India, Brazil, and Italy are driving growth in the vitamin D market.

Segmentation of the market by application comprises functional foods and beverages, pharmaceuticals, animal feed, and pet food, and personal care. Based on the application, the market is segmented as children, adults, and pregnant women.

On the basis of region, the vitamin D market is classified into North America, Europe, Asia Pacific, MEA, and Latin America. The Asia Pacific owes is growth in this sector to rapid growth in functional food, pharmaceutical, and feed industries in countries such as India and China. The growing awareness of vitamin D coupled with rising incidences of osteoporosis, osteomalacia, and rickets is probing to be healthy drivers to the market.

As per news article dated Jul 2016, the ingestion of vitamin D supplements in winter and autumn is recommended by a panel of health specialists in England.

The prescribed levels of dietary intake of vitamin D supplements should vary near or about 10mg for therapeutic use. The news also adds that only restorative properties of sunlight cannot be resorted to for providing vitamin D boosts as deficiencies in supplementary intake lead to brittle bones and rickets waiting to manifest itself.

It has come to light that one in five people suffer from Vitamin D deficiency in England and adequate supplementary advice in the form of dietary intake that augments scarcity in sunlight, the primary vitamin D source, and alleviate the onset of osteomalacia and weak bones are reasons to rejoice.

Nevertheless, it has been proven beyond doubt that vitamin D aids in bone formation and prevents disease of the bones.

Advice involving supplements in the diet with vitamin D top-up mitigates the ill-effects of its deficiencies for pregnant and breast-feeding women in particular.

This newfound deviation from earlier revelation regarding children up to five years and adults diagnosed with vitamin D deficiencies only to be given vitamin D boosts holds contemporary relevance owing to evidence such as application of sunscreen and showing less skin to sunlight by dressing down, giving ample reasons for vitamin D supplements to be monitored evenly.

Key industry players in the vitamin D market include Nestle SA, BASF, Pfizer, Inc., Koninklijke DSM NV, and ADM Alliance Nutrition, Inc.